Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
BMC Research Notes|March 6, 2010
Morphologic characterization of osteosarcoma growth on the chick chorioallantoic membraneMaurice Balke, Anna Neumann, Christian Kersting, et al.Cancer Research|December 4, 2002
Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitorsMartin Hagedorn, Lior Zilberberg, Jörg Wilting, et al.Developmental Dynamics : an Official Publication of the American Association of Anatomists|April 27, 2004
VEGF coordinates interaction of pericytes and endothelial cells during vasculogenesis and experimental angiogenesisMartin Hagedorn, Maurice Balke, Annette Schmidt, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|April 28, 2010
Topical and intravitreous administration of cationic nanoemulsions to deliver antisense oligonucleotides directed towards VEGF KDR receptors to the eyeTal Hagigit, Muhammad Abdulrazik, Faik Orucov, et al.International Journal of Cancer|July 18, 2009
Selective osteopontin knockdown exerts anti-tumoral activity in a human glioblastoma modelVirginie Lamour, Marie Le Mercier, Florence Lefranc, et al.Journal of Proteome Research|May 7, 2010
A combined metabonomic and transcriptomic approach to investigate metabolism during development in the chick chorioallantoic membraneRachel Cavill, Jasmin K Sidhu, Witold Kilarski, et al.BMC Cancer|June 15, 2011
A short-term in vivo model for giant cell tumor of boneMaurice Balke, Anna Neumann, Károly Szuhai, et al.International Journal of Cancer|December 20, 2007
Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastomaAhlame Saidi, Sophie Javerzat, Akeila Bellahcène, et al.Cell Division|March 1, 2007
FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patientsMartin Hagedorn, Maylis Delugin, Isabelle Abraldes, et al.Current Eye Research|August 21, 2002
Efficacy of Prinomastat) (AG3340), a matrix metalloprotease inhibitor, in treatment of retinal neovascularizationClaudio Garcia, Dirk-Uwe Bartsch, Maria E Rivero, et al.Pageof 4